Proteins have shown to act as a potential biomarker for several diseases, including cancers. Urine as a sample type is exciting in proteomics research. Read more about first-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies.
The study of various ''omics'' in urine offers potential for disease detection and monitoring . DNA and DNA modifications are particularly interesting in cancer research . Download the infographic below
Protecting against HPV infections through vaccination is critical and can reduce the risk of HPV related cancer development. First-void urine and HPV genotyping are essential tools to monitor the impact of vaccination.
Nearly all cervical cancers are caused by a persistent cervical infection with a high risk Human Papillomavirus (HPV). The global strategy set by WHO aims to accelerate the elimination of cervical cancer through improved uptake of vaccination and screening as well as timely treatment. These measures could lead to a world without cervical cancer.
The World Health Organization (WHO) calls for action to accelerate cervical cancer elimination by 2030. A key method to achieve this goal is improved screening. Urine as a sample type offers great potential to increase participation in cervical cancer screening programs.
October marks Breast Cancer Awareness Month. To improve breast cancer survival rates, screening and early detection is critical. Current screening methods have challenges. Alternative methods such as urine sampling is promising and can contain potential biomarkers for breast cancer. Download the...
The World Health Organization (WHO) envisions a world without cervical cancer . Novosanis supports this goal. Urine sampling for Human Papillomavirus (HPV), a common cause of cervical cancer, has the potential to reach more women, especially those who do not participate in traditional screening...